The Evaluation of Left Ventricular Systolic Function in Different Types of Ischemic Heart Disease
1 other identifier
observational
242
1 country
1
Brief Summary
The study was designed to evaluate the left ventricular longitudinal strain and strain rate assessed by 2D-STI in patients with coronary microvascular dysfunction (CMD) or obstructive coronary artery disease (CAD) , to investigate the effect of different types of ischemic heart disease on the LV systolic function, and to explore the value of LS on the diagnosis of coronary microvascular dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedFirst Submitted
Initial submission to the registry
June 27, 2021
CompletedFirst Posted
Study publicly available on registry
July 13, 2021
CompletedJuly 13, 2021
July 1, 2021
8 months
June 27, 2021
July 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
global longitudinal strain
global longitudinal strain of CMD group and obstructive CAD group
15/3/2018-30/12/2018
Study Arms (3)
coronary microvascular dysfunction group
obstructive coronary artery disease
control group
Interventions
lobal longitudinal strain and strain rate, subendocardial LS and subepicardial LS were quantified by two dimensional speckle tracking imaging
Eligibility Criteria
A total of 242 patients were enrolled, including 102 males (42.1%) and 140 females (57.9%). Their ages ranged from 44 to 81 years, with an average age of (62.6 + 8.3) years.
You may qualify if:
- age from 18-85 years
You may not qualify if:
- patients with history of myocardial infarction or abnormal wall motion suggested by conventional echocardiography
- patients with acute heart failure, chronic heart failure or LVEF values less than 50%
- patients with congenital heart disease, severe valvular disease, severe bradycardia, high atrioventricular block and atrial fibrillation
- patients who did not store ultrasound images or whose ultrasound images were unclear
- patients who had incomplete clinical data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, Peking University Third Hospital, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Li Zhaoping, professor
Peking University Third Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2021
First Posted
July 13, 2021
Study Start
March 15, 2018
Primary Completion
October 30, 2018
Study Completion
December 30, 2018
Last Updated
July 13, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share